Contact

Merge Healthcare Appoints Dr. Cheryl Whitaker as Chief Medical Officer At Merge, Dr. Cheryl Whitaker will help guide new product strategy designed to enhance the company’s product portfolio as well as support new federal healthcare initiatives.

Merge Healthcare Appoints Dr. Cheryl Whitaker as Chief Medical Officer

Experienced clinician will help shape product strategy and interface with industry organizations

Merge Healthcare Incorporated (NASDAQ: MRGE), a global corporation dedicated to health IT interoperability solutions, today announced the appointment of Cheryl Whitaker, MD, MPH, FACP, to serve as the company’s first Chief Medical Officer. Dr. Whitaker was previously at the Chicago Community Trust, where she directed the strategy and priorities for funds that support the health of the Chicago region. She also was recently appointed by Governor Quinn to the Board of Directors of the Illinois Health Information Exchange Authority.

At Merge, Dr. Whitaker will help guide new product strategy designed to enhance the company’s product portfolio as well as support new federal healthcare initiatives. She will also act as Merge’s liaison with clinician-focused industry organizations as the company continues its focus on improving the usability and interoperability of electronic healthcare.

“With the evolution of electronic healthcare and the changing healthcare landscape, Merge is developing of a variety of new and enhanced products and services. Dr. Whitaker will be a valuable resource in helping us optimize our offerings to meet the needs of both patients and the medical community,” said Jeff Surges, Merge’s CEO. “As a former practicing physician with a long-time commitment to improving the healthcare delivery system, she is an ideal choice to help us build an increasingly stronger healthcare information platform.”

Prior to joining the Chicago Community Trust, she was an Assistant Professor of Preventive Medicine at Rush University Medical Center in Chicago. There, she conducted research to determine the impact of lifestyle factors that affect the overall health and quality of living. She also received funding from the National Institutes of Health to work in low-income communities with people living with chronic diseases.

Dr. Whitaker has been repeatedly recognized for her research and service to the medical field. In October 2009, she was awarded the Chapter Laureate Award by the Illinois Chapter of the American College of Physicians for her outstanding contributions in medicine to the State of Illinois. As a junior faculty member at Rush University Medical Center, she was awarded the Midwest Trainee Investigator Award given by the Central Society for Clinical Research. While training as a hypertension specialist at Rush, she received the GlaxoSmith Kline Medical Fellowship Award, which recognizes emerging leaders in hypertension treatment and research for underserved populations. She was also the recipient of the Secretary of Health and Human Services Award for Innovations in Health for her proposal to develop an exercise program for urban African-American women when she was a student at the Harvard School of Public Health.

Dr. Whitaker holds degrees from the Washington University School of Medicine and the Harvard School of Public Health. She completed her training in Internal Medicine at Stanford University and the University of California, San Francisco.

Merge Healthcare Incorporated develops and integrates information technology to create a better electronic healthcare experience. Merge products, ranging from standards-based development toolkits to sophisticated clinical applications, have been used by healthcare providers, vendors and researchers worldwide for over 20 years. Additional information can be found at www.merge.com.

Cautionary Notice Regarding Forward-Looking Statements
The matters discussed in this news release may include forward-looking statements, which could involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.

Press Contact:
Brenda Stewart
Director of Marketing Communications
312-540-6622
brenda.stewart@merge.com

 

© 2017 IBM Watson Health. All Rights Reserved. Privacy | Terms | Email Signup | Sitemap